Dr. Osborne is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6045 Pebblebrook Lane
Apt#80
Kent, OH 44240Phone+1 937-701-2250
Education & Training
Northeast Ohio Medical UniversityClass of 2025
Publications & Presentations
PubMed
- 11 citationsCYP4V2 fatty acid omega hydroxylase, a druggable target for the treatment of metabolic associated fatty liver disease (MAFLD).Nicholas Osborne, Charles Leahy, Yoon-Kwang Lee, Paula Jean Rote, Byoung-Joon Song
Biochemical Pharmacology. 2021-11-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
